The advertisement promotes NUBEQA (darolutamide), a medication for prostate cancer that has spread to other parts of the body. It provides important safety information regarding medical conditions and potential risks associated with the drug.
Creative Information
| CID: | f0d2dd89-cab2-4a4d-a052-6326576da81e |
| CRID: | 82_1075-793604 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $1.86 |
| Timestamp: | 10/31/2025, 1:37:37 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/10/2025, 1:45:58 AM | 7.39s | |
| adomain_analysis | success | 11/19/2025, 2:23:17 AM | 2.37s | |
| adomain_capture | success | 11/19/2025, 2:23:15 AM | 0.12s | |
| ad_render | success | 11/18/2025, 10:00:57 PM | 24.41s | |
| brand_mapping | success | 11/18/2025, 8:35:33 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1428.38 KB | ||||||||||||||||||||||
| Render Time: | 8.94 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1844.66 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Landing Page
Creatives
